Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$242.49 - $301.46 $2.28 Million - $2.83 Million
9,389 New
9,389 $2.31 Million
Q2 2019

Aug 09, 2019

SELL
$250.96 - $284.94 $340,301 - $386,378
-1,356 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$276.39 - $362.25 $374,784 - $491,211
1,356 New
1,356 $387,000
Q4 2018

Feb 11, 2019

SELL
$281.08 - $444.25 $666,440 - $1.05 Million
-2,371 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$354.53 - $449.75 $147,839 - $187,545
-417 Reduced 14.96%
2,371 $1.07 Million
Q2 2018

Aug 09, 2018

BUY
$278.07 - $446.21 $775,259 - $1.24 Million
2,788 New
2,788 $1.14 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.